Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBloating on Mounjaro is common, particularly in the first few weeks of treatment. Tirzepatide slows the rate at which your stomach empties, which keeps food in the gut longer and can cause gas, fullness and that tight, uncomfortable distension. It usually settles as your body adjusts, though the right habits make a real difference. These are prescription-only medicines; a clinician assesses whether they're right for you before any treatment begins. Find out more about how Mounjaro works if you want the full mechanism before reading on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both GIP and GLP-1 receptors, two gut-hormone pathways that your body uses to regulate appetite and blood sugar. One effect of that activation is slowed gastric emptying: your stomach releases food into the small intestine more gradually. That slower transit is part of why appetite falls on treatment, but it also means food, liquid and fermented gas spend more time in the upper gut than they did before.
The result, for many people, is a bloated, full feeling that can linger well past mealtimes, and if you want to understand why Mounjaro makes you feel bloated at a physiological level, that detail is covered in full. It tends to be most noticeable in the first two to four weeks, and it often flares again for a week or two after each dose increase. Read a fuller breakdown of bloating on Mounjaro if you want to understand the physiology in more detail.
The NHS patient information for tirzepatide lists bloating and indigestion among the recognised side effects, alongside nausea, constipation and diarrhoea. Knowing this is expected doesn't make it comfortable, but it does mean you're not experiencing something unusual.
A question our prescribers hear most weeks is whether the bloating can be reduced without stopping treatment. The honest answer is: usually yes, with some straightforward dietary changes.
Fermentable carbohydrates ferment in the gut and produce gas. On Mounjaro, with slower emptying, that gas has more time to accumulate. Common offenders include onions, garlic, beans, lentils, cabbage, apples and fizzy drinks. A temporary reduction, not permanent elimination, often helps significantly. Some people find a lower-carbohydrate approach also reduces bloating alongside supporting weight loss, though dietary changes are best discussed with your prescriber or a dietitian.
Eating speed matters too. Eating slowly, chewing thoroughly, and keeping portions smaller than before treatment all reduce the volume of air and undigested food that the stomach has to manage at once. Lying down immediately after eating compounds the problem. Even a short walk after meals can help move things along. Carbonated drinks, straws and chewing gum all introduce extra air that has nowhere to go quickly when emptying is slow.
High-fat meals are another trigger. Fat already delays gastric emptying even without medication; combined with tirzepatide's effect, it can produce prolonged, uncomfortable fullness. Lighter meals more frequently often work better than three large ones.
Bloating that appears or worsens when your dose increases is almost always temporary. The standard titration schedule starts at 2.5mg (a dose that exists specifically to let your system adapt) and moves upward in steps decided by your prescriber. Each step asks the gut to adjust again, and a week or two of increased bloating is a recognised part of that process.
Keeping a simple food and symptom diary for two weeks after each increase is genuinely useful. It often reveals a pattern: a particular meal, a time of day, a food combination. That information is far more actionable than a general sense that 'everything bloats me'. More on managing bloating across the titration schedule is available if you're mid-increase and looking for practical steps.
Most people report that bloating largely resolves, or drops to an occasional mild inconvenience, by the time they've been on a stable dose for three to four weeks. If it stays severe, or is getting worse rather than better, that's a conversation to have with your prescriber before the next dose change.
There's also a useful cost-of-treatment context here: understanding what's included in private treatment (including ongoing prescriber access for exactly these kinds of questions) matters when you're assessing your options.
Most bloating on tirzepatide is uncomfortable rather than dangerous. There are situations, though, where it signals something that needs prompt assessment.
Severe or persistent stomach pain that spreads toward your back, with or without vomiting, should be assessed by a doctor urgently. This symptom pattern can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines as an infrequent but serious risk. It's rare, but it's the symptom that should never be waited out.
Similarly, if bloating is accompanied by significant vomiting that makes it difficult to keep fluids down, or if you're developing signs of dehydration (dizziness, dark urine, reduced urination) seek medical help the same day. Prolonged vomiting on GLP-1 treatment can lead to kidney problems through dehydration.
General bloating that is merely persistent and uncomfortable is different. That's a quality-of-life issue worth discussing at your next clinical review, not a reason to attend urgent care. More on what severe bloating on Mounjaro does and doesn't indicate may help you gauge where your symptoms sit. If you're unsure, our team is available seven days a week.
You can also report unexpected or concerning side effects through the MHRA's Yellow Card scheme, which helps regulators track the real-world safety picture for medicines like tirzepatide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.